The tumor suppressor Fbxw7 (also known as hCdc4, hAgo, or Fbw7) is an F-box protein that functions as the substraterecognition subunit of an SCF ubiquitin ligase complex and targets a group of oncoproteins for degradation. We now show that Fbxw7 regulates the proliferation and differentiation of keratinocytes by mediating the degradation of c-Myc and Notch proteins. Fbxw7-deficient keratinocytes showed an increased proliferative capacity that was dependent on the accumulation of c-Myc but not on that of Notch. Fbxw7 deficiency also resulted in the premature differentiation of keratinocytes in a manner dependent on both c-Myc and Notch. Although Fbxw7-deficient keratinocytes proliferated excessively in vitro, loss of Fbxw7 did not predispose keratinocytes to the formation of squamous cell carcinoma in vivo induced by the expression of oncogenic Ras, possibly because the stem cell population of keratinocytes becomes exhausted as a result of enhanced Notch activity. Indeed, suppression of Notch signaling by additional ablation of RBP-J in Fbxw7-deficient keratinocytes conferred a more aggressive tumorigenic capacity. Collectively, these results indicate that Fbxw7 controls the proliferation and differentiation of keratinocytes, and that it exerts both inhibitory and stimulatory actions in skin carcinogenesis by counteracting the proliferation-promoting effect of c-Myc and the tumor-suppressive effect of Notch, respectively.
INTRODUCTION
Coordination between protein synthesis and degradation governs diverse biological phenomena including cell proliferation, differentiation and apoptosis, and dysregulation of proteolysis pathways, such as the ubiquitin-proteasome system, underlies numerous pathological conditions including cancer. 1 The SCF family of ubiquitin ligase complexes includes some of the most well-characterized mammalian ubiquitin ligases. 2 An F-box protein, including Fbxw7 (also known as Sel-10, hCdc4, hAgo, or Fbw7) serves as the substrate-recognition subunit of the SCF complex. 3 Fbxw7 targets a subset of oncogenic proteins, including c-Myc, 4 ,5 cyclin E [6] [7] [8] and Notch. [9] [10] [11] [12] [13] A recent comprehensive analysis of primary human tumors found Fbxw7 gene mutations in diverse tumor types and implicated the Fbxw7 gene as a general tumor suppressor gene. 14, 15 Studies with multiple animal models have provided further support for the role of Fbxw7 as a tumor suppressor. Conditional deletion of Fbxw7 in T cells or hematopoietic stem cells of mice thus resulted in T-cell lymphoma or leukemia, respectively. [16] [17] [18] In addition, mice heterozygous for null mutations of both Fbxw7 and p53 showed an increased propensity to develop thymic lymphoma and various carcinomas. 19, 20 However, we previously showed that Fbxw7 deletion in mouse embryonic fibroblasts resulted in impairment of cell proliferation as a consequence of an increase in the activity of Notch. 21, 22 Together, these findings thus suggest that the role of Fbxw7 in cell proliferation and oncogenesis varies in a tissuespecific manner.
Notch is a key substrate of Fbxw7 and performs various functions that are dependent on developmental stage or cellular context. 23 Whereas Notch is a bona fide oncoprotein in various tissues, it serves as a tumor suppressor in others, including skin. 24 Skin-specific inactivation of Notch1 in mice results in hyperproliferation of keratinocytes, eventually leading to the development of sporadic tumors as well as to an increased susceptibility to that of chemical-induced tumors. 25, 26 Inhibition of endogenous Notch signaling in normal human keratinocytes by expression of a dominant negative form of the Notch coactivator Mastermind also promoted the formation of squamous cell carcinoma (SCC) on introduction of the cells into nude mice. 27 Furthermore, the abundance of Notch1 mRNA was found to be reduced in a subset of human SCC specimens. 27 These observations thus suggest that Fbxw7 may function as an oncoprotein in keratinocytes through degradation of Notch.
In the current study, we show that Fbxw7-deficient keratinocytes have an increased proliferative capacity and undergo premature differentiation, whereas they exhibit a reduced stem cell potential. In addition, induction of tumor formation by an oncogenic form of H-Ras was suppressed in Fbxw7-deficient keratinocytes as a result of the accumulation of Notch. Our data suggest that Fbxw7 has a key role in control of the proliferation and differentiation of keratinocytes. Fbxw7 performs two conflicting functions in skin carcinogenesis, promoting and inhibiting tumor formation by mediating the degradation of Notch and c-Myc, respectively.
RESULTS

Fbxw7 deficiency results in accumulation of target proteins in keratinocytes
We adopted the Cre-loxP system to target Fbxw7 for deletion in keratinocytes, as conventional Fbxw7 knockout mice resulted in the early embryonic death. 28, 29 Primary keratinocytes were prepared from neonatal mice homozygous for a floxed Fbxw7 allele (Fbxw7 F/F mice), 17 (Figure 1a) .
We compared the abundance of Fbxw7 substrates between (Figure 2e) . Paradoxically, however, the levels of cleaved forms of caspase-3 and poly(ADP-ribose) polymerase were markedly increased in Fbxw7-deficient keratinocytes compared with those in control cells (Figure 2f ). Overexpression of c-Myc was previously shown to induce apoptosis in keratinocytes, 30 whereas Notch signaling protects these cells from apoptosis. 31 The increased level of apoptosis observed in Fbxw7-deficient keratinocytes may therefore be related to the accumulation of c-Myc, rather than to that of Notch1, in these cells. Together, these results indicated that ablation of Fbxw7 in keratinocytes induced a hyperproliferative phenotype through promotion of cell cycle progression as well as inhibition of cell senescence and an associated increase in the frequency of apoptosis. keratinocytes exhibited a hyperproliferative phenotype similar to that of Fbxw7 D/D keratinocytes, whereas deletion of Rbpj alone had no effect on cell proliferation (Figure 3d) (Figure 4a ). To assess whether inactivation of Fbxw7 modulates the differentiation program, we monitored differentiation by analysis of differentiation-specific proteins. In skin, keratinocytes begin to express keratin1, keratin10 and involucrin in the spinous layer, whereas filaggrin is expressed in the granular layer and above. 32 
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D/D keratinocytes expressed keratin1 at a relatively high (Figure 4f ). Furthermore, the cyclin-dependent kinase inhibitor roscovitine did not substantially affect the increase in keratin1 expression induced by Fbxw7 loss (Figure 4g ), excluding the possibility that promotion of the cell cycle per se accelerates keratinocyte differentiation.
We also examined the expression of keratin1 and keratin10 at the mRNA level in Fbxw7 Loss of Fbxw7 does not promote Ras-induced tumorigenesis c-Myc transforms primary cells cooperatively with the Ras oncoprotein. 33 A transgenic mouse expressing c-Myc constitutively in basal keratinocytes shows increased susceptibility to two-stage skin carcinogenesis that is dependent on oncogenic Ras activity. 34 We examined whether the loss of Fbxw7 influences Rasdriven oncogenic transformation with a retrovirus encoding constitutively activated Ras (H-Ras G12V ). We used a low titer of the retrovirus for infection to avoid the induction of premature senescence. Both the hyperproliferative phenotype (Figure 5a ) and the accumulation of Fbxw7 substrates (Figure 5b ) induced by Fbxw7 loss remained apparent in keratinocytes after introduction of the Ras oncogene. (Figures 2a and 5a) , the tumors originating from Fbxw7 D/D H-Ras G12V keratinocytes were smaller than those derived from Fbxw7 F/F H-Ras G12V keratinocytes (Figures 5c and d) . Histological analysis revealed that the tumors that developed from Fbxw7 F/F H-Ras G12V keratinocytes had a poorly differentiated, highly invasive SCC phenotype (Figure 5e and Table 1 ). In (Figure 5f ). These results indicated that, in contrast to the hyperproliferation of Fbxw7-deficient keratinocytes observed in vitro, the loss of Fbxw7 does not promote, but rather suppresses, Ras-driven tumorigenesis.
Combined deletion of Fbxw7 and Rbpj accelerates Ras-driven tumor growth Cancer cells are thought to arise from stem or early progenitor cells. 35, 36 We examined whether a decrease in the number or potential of epidermal stem cells was responsible for the observed reduced susceptibility of Fbxw7 D/D keratinocytes to Ras-induced carcinogenesis. To analyze stem cell function, we performed clonogenicity assays with the use of a fibroblast feeder layer and growth factors. 37, 38 Colonies that are large, round and actively growing are thought to be derived from keratinocyte stem cells because immature keratinocytes are induced to actively proliferate under these conditions. Fbxw7 D/D keratinocytes yielded colonies that did not differ morphologically or in the expression of differentiation markers from those formed by control cells (data not shown), whereas the number of colonies formed by the Fbxw7-deficient cells was moderately but significantly reduced (Figure 6a ), supporting the possibility that the stem cell fraction of Fbxw7-deficient keratinocytes was reduced. Given that Notch induces premature differentiation, we examined whether the accumulation of Notch might promote exhaustion of stem cells. Deletion of Rbpj in Fbxw7 D/D keratinocytes indeed restored stem cell number (Figure 6a ). Notch1 was shown to negatively regulate the protein kinases ROCK and MRCKa, both of which contribute to the control of cell motility and differentiation marker expression in keratinocytes. 27 The amounts of ROCK1, ROCK2 and MRCKa mRNAs in Fbxw7 D/D keratinocytes were significantly reduced compared with those in control cells but were normalized by the additional deletion of Rbpj (Figure 6b ). These results suggested that the enhanced Notch activity in Fbxw7 D/D keratinocytes might limit the cell invasiveness required for three-dimensional tumor growth in vivo.
Finally, we injected Fbxw7 Table 2 ). In contrast, tumors formed from Fbxw7 
DISCUSSION
We have shown that loss of Fbxw7 in keratinocytes induces hyperproliferation in culture that is attributable to c-Myc accumulation. However, keratinocytes deficient in Fbxw7 show a reduced susceptibility to Ras-induced tumorigenesis in vivo as a result of the tumor-suppressive activity of accumulated Notch. Fbxw7 deficiency, which promotes tumor formation in certain situations, thus paradoxically results in tumor suppression in primary keratinocytes. The relation between c-Myc and Notch, both of which are key substrates of Fbxw7 in keratinocytes, appears complex. c-Myc, but not Notch, is responsible for the hyperproliferation of Fbxw7-deficient keratinocytes, whereas both c-Myc and Notch promote the early onset of differentiation in these cells in a cooperative manner. Furthermore, c-Myc and Notch act antagonistically to regulate Rasinduced skin tumorigenesis.
Among the B70 F-box proteins in humans, only a few have been extensively characterized. 1 One example of such an F-box Fbxw7 and keratinocyte growth differentiation Y Ishikawa et al protein is Skp2, which primarily targets the cyclin-dependent kinase inhibitors p27, p21 and p57, each of which is thought to be a negative regulator of the cell cycle. Consistent with the spectrum of Skp2 substrates, many tumors overexpress this protein, suggesting that the Skp2 gene serves as an oncogene. Fbxw7 preferentially targets proteins that promote cell growth, such as cyclin E, c-Myc, Notch, c-Jun and mTOR, as well as the antiapoptotic protein Mcl-1. Indeed, Fbxw7 gene mutations have been detected in a variety of human malignancies. In addition, b-TrCP regulates multiple signaling pathways, such as those mediated by Wnt, NF-kB and Sonic Hedgehog by targeting b-catenin, IkB and Gli-3, respectively, although this F-box protein is also functionally versatile. These findings suggest that each F-box protein might target a group of substrates with a similar function. 1 However, our present results appear inconsistent, at least in part, with this notion and await further clarification. The ubiquitin-proteasome system is able to perform different functions in different cell types because it is regulated at many levels, including the E3 ligase (such as Fbxw7), expression of substrates (such as c-Myc), substrate phosphorylation by protein kinases (such as GSK-3b) and inputs by putative phosphatases and deubiquitinases. Many Given this variety of phenotypes in different cell types, it remained important to examine the substrates targeted by Fbxw7 for degradation as well as the phenotype associated with Fbxw7 loss in keratinocytes.
Maintenance of stemness in epidermal stem cells requires p63 function, which is suppressed by Notch1. [41] [42] [43] Fbxw7 may therefore affect epidermal stem cells through negative regulation of p63 by the Notch pathway. Small GTPases of the Rho family, including Rho, Rac and Cdc42, are also known to regulate keratinocyte proliferation and fate determination. 44, 45 Genetic suppression of Notch signaling together with activation of Ras in keratinocytes was previously shown to give rise to the development of aggressive SCC, 27 which was partially explained by an increase in the expression of ROCK1, ROCK2 and MRCKa, all of which function downstream of Rho-family GTPases. Thus, whereas Notch1 downregulated the expression of these kinases, tumor formation was abrogated by their inhibition. We found that the abundance of ROCK1, ROCK2 and MRCKa mRNAs was downregulated in Fbxw7-deficient keratinocytes, and that deletion of Rbpj reversed this effect as well as enhanced tumor formation by these cells. Fbxw7 thus likely regulates keratinocyte properties by influencing Notch-dependent regulation of smallGTPase signaling pathways.
We have now shown that Fbxw7 regulates keratinocyte differentiation through not only Notch but also c-Myc. Pharmacological inhibition of Notch activity thus further downregulated keratin1 expression in keratinocytes lacking both Fbxw7 and c-Myc. The mechanism of action of c-Myc in the promotion of keratinocyte differentiation seems to differ from that of Notch. The relative extents of the contributions of Notch and c-Myc to keratinocyte differentiation remain to be determined.
In conclusion, we have found that disruption of Fbxw7 in keratinocytes affected the proliferation, differentiation and susceptibility to Ras-induced tumorigenesis of these cells. Our results thus suggest that Fbxw7 does not function simply as a tumor suppressor. Given that the balance between Notch and multiple oncoproteins including c-Myc is a pivotal determinant of homeostasis in epithelial tissues, Fbxw7 appears to be a key molecule in regulation of the differentiation and proliferation of epidermal stem cells. Our findings provide new insight into not only control of the proliferation and differentiation of keratinocytes but also the complex mechanism underlying tumorigenesis in epithelial tissues.
MATERIALS AND METHODS
Cells and viral infection
We have previously generated mice homozygous for a floxed Fbxw7 allele (Fbxw7 F/F mice). 17 Rbpj F/F mice 46 and c-Myc F/F mice 47 were kindly provided by T Honjo and IM de Alborán, respectively. Primary keratinocytes were prepared from neonatal mice as described. 42 The cells were cultured in minimal essential medium supplemented with Chelex-treated fetal bovine serum (4%), epidermal growth factor (10 ng/ml; Gibco, Billings, MT, USA) and 0.05 mM CaCl 2 . For Ca 2 þ -induced differentiation, confluent cultures of keratinocytes were incubated in the same medium containing CaCl 2 at a final concentration of 2 mM.
Complementary DNAs encoding human H-Ras G12V , Cre recombinase, or mouse NICD1 were subcloned into the retroviral vector pMX-puro. 48 Plat-Epackaging cells were transfected with the retroviral vectors, and culture supernatants containing recombinant ecotropic retroviruses were harvested. Conditional inactivation of Fbxw7, Rbpj, or c-Myc was performed by infection of keratinocytes with the retrovirus encoding Cre recombinase. Infected keratinocytes were subjected to selection in medium containing puromycin (10 mg/ml) for at least 72 h. Cells were studied at 5 days after infection, unless indicated otherwise.
Both of DAPT and Roscovitine were obtained from Calbiochem (San Diego, CA, USA), were dissolved in dimethyl sulfoxide, the final concentration of which in culture medium was 0.1%. Culture medium supplemented with the reagent was changed every day.
Quantitative RT-PCR analysis Total RNA was isolated and complementary DNA synthesized as described previously. 21 Real-time PCR analysis was performed with an Applied Biosystems 7000 sequence detection system and the Power SYBR green dye (Applied Biosystems, Foster City, CA, USA). Data were analyzed according to the 2 -DDCt method and were normalized relative to the amount of ARBP (acidic ribosomal phosphoprotein P0) mRNA or HPRT (hypoxanthine-guanine phosphoribosyltransferase) mRNA.
Cell cycle analysis and immunostaining of BrdU
For cell cycle analysis, cells were incubated with 10 mM BrdU (Sigma, St Louis, MO, USA) for 4 h and were then stained and analyzed as previously described. 21 For immunostaining of BrdU, cells were labeled with BrdU for the last 3 h of culture and was detected with antibodies to BrdU (3D4, BD 
Abbreviations: NA, not applicable; ND, not done.
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Biosciences, San Diego, CA, USA) and FITC-conjugated secondary antibodies (Cappel, West Chester, PA, USA). The BrdU incorporation rate was determined by fluorescence microscopy as the number of BrdUpositive cells divided by the total number of cells positive for nuclear staining with Hoechst 33342 (1 mg/ml, Molecular Probes, Invitrogen, Carlsbad, CA, USA).
Protein analysis
Immunoblot analysis was performed as described. 49 Antibodies to Notch3 (M-134), c-Myc (N262), c-Jun (H-79), cyclin E (M20) and H-Ras (C-20) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA); those to keratin1, filaggrin and involucrin were from Covance (Emeryville, CA, USA); those to cleaved Notch1, cleaved caspase-3, cleaved poly(ADP-ribose) polymerase, phospho-c-Myc (Thr 58 /Ser
62
) and phospho-c-Jun (Ser   63   ) were from Cell Signaling Technology (Canvers, MA, USA); those to Hsp90 were from BD Pharmingen (San Diego, CA, USA); and those to a-tubulin (B-5-1-2) were from Sigma. For analysis of protein stability, cells were exposed to cycloheximide (20 mg/ml) and harvested at the indicated times thereafter. Quantitation of chemiluminescence signals was performed with a digital imaging system (VersaDoc; Bio-Rad, Hercules, CA, USA). 
Clonogenicity assays
Primary keratinocytes were harvested by exposure to trypsin, passed through an 85-mm filter and counted. For the cell-autonomous growth assay, keratinocytes (1 Â 10 5 ) in regular low-Ca 2 þ culture medium were seeded onto a plain 60-mm culture dish. For coculture with fibroblasts, keratinocytes (5 Â 10 2 ) were transferred to a feeder layer of 3T3 fibroblasts that had been treated with mitomycin C (Kyowa Hakko, Tokyo, Japan) at 12.5 mg/ml. The cocultures were maintained at 32 1C under a humidified atmosphere of 5% CO 2 .
Senescence assay Cellular senescence was determined by detection of senescence-associated b-galactosidase activity with the use of a Senescence Assay kit (Biovision, Mountain View, CA, USA).
Tumorigenicity assay
At 2-3 days after plating, primary keratinocytes were infected with a retrovirus encoding H-Ras G12V (pMX-puro-H-Ras
G12V
) and either a retrovirus encoding Cre recombinase (pMX-puro-Cre) or the empty virus (pMX-puro). At 24 h after infection, the cells were subjected to selection in medium containing puromycin (10 mg/ml). In some experiments, cells were infected with a combination of pMX-puro-H-Ras G12V and either pMX-Cre-SV40-GFP or pMX-SV40-GFP and were subjected to selection with puromycin at 1 mg/ ml; expression of green fluorescent protein (GFP) was not analyzed in these experiments. Cells were injected subcutaneously into nude mice. Ras-transformed keratinocytes with or without target gene deletion were injected into the same animals on the left and the right sides, respectively. The end point of the assay was set as either 8 weeks after cell injection or the major axis of the tumor achieving a length of 1.5 cm, whichever occurred earlier. The animal experiments were approved by the animal ethics committee of Tohoku University.
Statistical analysis
Quantitative data are presented as means ± s.e. and were analyzed by Student's t-test. Numbers of repeat experiments are indicated in figure legends. A P-value of o0.05 was considered statistically significant.
